Thanks to its longstanding presence in China, NNE Pharmaplan was able to build a production facility within local cost constraints to supply enzymes to support the growing market.

On 27 November 2006, a production facility that makes enzymes was inaugurated in Hongda, 80 kilometres northwest of Shanghai. Built by NNE Pharmaplan for Novozymes and Suzhou Hongda Enzyme Company, the facility is a perfect example of using local resources to have a global impact.

 

Longstanding local presence is key
The investment cost of this enzyme production facility was a significant factor in this project. Another important element was purchasing, as the majority of the facility’s process equipment came from local suppliers.

In both respects, the project benefited from NNE Pharmaplan’s 10-plus years of experience with Chinese engineering and construction projects. Its local presence and acquaintance with the best local suppliers and contractors helped keep prices down and the timeframe short – with the project realised in just 18 months.

High-quality, cost-efficient GMP facility
The project was executed by NNE Pharmaplan’s Chinese subsidiary and included detail design, purchasing, equipment supervision, construction management and project management.

Using the latest design technology – including sophisticated 3D design tools for cross-checking – and state-of-the-art products produced in China, the end result was a high-quality enzyme production facility that met or surpassed all expectations.